28
Oct
2025
Medichem S.A.
Exhibitor at CPHI Frankfurt 2025 stand 3.0F80, Finished Dosage Formulations
About Us
Categories
-
ES
-
2015On CPHI since
-
250 - 499Employees
Company types
Event information
CPHI Frankfurt 2025
-
28 Oct 2025 - 30 Oct 2025
-
Messe, Frankfurt
-
Visit us at stand 3.0F80, Finished Dosage Formulations
Products Featured at CPHI Frankfurt 2025
-
Product SUGAMMADEX SODIUM FDF
SOLUTION FOR INJECTION ANESTHESIA FDF -
Product PRUCALOPRIDE succinate FDF
film-coated tablets - chronic constipation FDF -
Product DAPTOMYCIN FDF
Medichem S.A. offers wide range of finished dosage forms for licencing which includes Daptomycin. Indication: Antibiotic. Pharmaceutical form: Powder for solution for injection or infusion in glass vial. Strength: 350 mg, 500 mg. Dossier status: EU filed. -
Product RIVAROXABAN FDF
Medichem S.A. offers wide range of pharmaceutical APIs and FDF which includes Rivaroxaban. Indication: Antithrombotic. Contact us for more information. -
Product SUNITINIB MALATE FDF
Medichem S.A. offers a wide range of finished dosage forms for licencing which includes Sunitinib Malate. Indication: Kidney Cancer/ GIT Stromal Tumors. Pharmaceutical form: Capsules. Strength: 12.5 mg, 25 mg, 37.5 mg, 50 mg. Dossier status: EU filed.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance